Skip to content
RP
Company

Updated:

Rich Pharmaceuticals, Inc.

Rich Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001504389, and its reported...

Overview

Rich Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001504389, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-07-17, it reported annual revenue of USD 115,000; net income of USD -1,692,341; total assets of USD 37,429 for the fiscal period ended 2018-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Rich Pharmaceuticals, Inc.
Former names in filing history
Nepia Inc. (2011-04-25 to 2013-08-19)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Los Angeles, CA, United States
Incorporated in
WY
Fiscal year end
March 31
SEC CIK
0001504389

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2018USD$115,000-$1.7M$37,429$6,222-$508,479
FY2017USD—-$3.2M$53,028$40,903-$553,394
FY2016USD—-$1.8M$6,531—-$495,099
FY2015USD$0-$4.1M$24,258$15,892-$1.4M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
8-K8-K
10-K10-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
S-1—S-1
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Rich Pharmaceuticals, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Rich Pharmaceuticals, Inc. | Los Angeles Company | Altss